Proactiveinvestors USA & Canada Cleveland BioLabs https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Cleveland BioLabs RSS feed en Thu, 03 Dec 2020 06:42:04 -0500 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Cleveland BioLabs shares rocket on progress of anti-radiation drug candidate https://www.proactiveinvestors.com/companies/news/176473/cleveland-biolabs-shares-rocket-on-progress-of-anti-radiation-drug-candidate-176473.html Mon, 17 Apr 2017 15:12:00 -0400 https://www.proactiveinvestors.com/companies/news/176473/cleveland-biolabs-shares-rocket-on-progress-of-anti-radiation-drug-candidate-176473.html Cleveland BioLabs highlights entolimod data https://www.proactiveinvestors.com/companies/news/122330/cleveland-biolabs-highlights-entolimod-data-122330.html Tue, 09 Feb 2016 14:38:00 -0500 https://www.proactiveinvestors.com/companies/news/122330/cleveland-biolabs-highlights-entolimod-data-122330.html Cleveland Biolabs starts dosing in CBLB612 mid-stage study https://www.proactiveinvestors.com/companies/news/121772/cleveland-biolabs-starts-dosing-in-cblb612-mid-stage-study-121772.html Tue, 26 Jan 2016 13:43:00 -0500 https://www.proactiveinvestors.com/companies/news/121772/cleveland-biolabs-starts-dosing-in-cblb612-mid-stage-study-121772.html Cleveland BioLabs ups stake in Panacela Labs https://www.proactiveinvestors.com/companies/news/120755/cleveland-biolabs-ups-stake-in-panacela-labs-120755.html Tue, 22 Dec 2015 15:02:00 -0500 https://www.proactiveinvestors.com/companies/news/120755/cleveland-biolabs-ups-stake-in-panacela-labs-120755.html Cleveland BioLabs sees positive pre-clinical results from neuroblastoma drug https://www.proactiveinvestors.com/companies/news/87268/cleveland-biolabs-sees-positive-pre-clinical-results-from-neuroblastoma-drug-30866.html Thu, 21 Jun 2012 19:22:00 -0400 https://www.proactiveinvestors.com/companies/news/87268/cleveland-biolabs-sees-positive-pre-clinical-results-from-neuroblastoma-drug-30866.html Cleveland inks funding deal for Panacela unit with Russia's RUSNANO https://www.proactiveinvestors.com/companies/news/80093/cleveland-inks-funding-deal-for-panacela-unit-with-russias-rusnano-18842.html Mon, 26 Sep 2011 06:20:00 -0400 https://www.proactiveinvestors.com/companies/news/80093/cleveland-inks-funding-deal-for-panacela-unit-with-russias-rusnano-18842.html Cleveland BioLabs' drug to treat lethal doses of radiation granted orphan status by US FDA https://www.proactiveinvestors.com/companies/news/75138/cleveland-biolabs-drug-to-treat-lethal-doses-of-radiation-granted-orphan-status-by-us-fda-10468.html Tue, 30 Nov 2010 22:01:00 -0500 https://www.proactiveinvestors.com/companies/news/75138/cleveland-biolabs-drug-to-treat-lethal-doses-of-radiation-granted-orphan-status-by-us-fda-10468.html US Dept of Defense awards Cleveland BioLabs $45m contract for radiation counter-measure drug https://www.proactiveinvestors.com/companies/news/69143/us-dept-of-defense-awards-cleveland-biolabs-45m-contract-for-radiation-counter-measure-drug--8503.html The $45 million contract, which was awarded by the US DoD's Chemical Biological and Medical Systems (CBMS) and Medical Identification and Treatment Systems (MITS) departments, is worth roughly 40% of Cleveland BioLabs' $144 million market capitalization.

]]>
Fri, 17 Sep 2010 19:34:00 -0400 https://www.proactiveinvestors.com/companies/news/69143/us-dept-of-defense-awards-cleveland-biolabs-45m-contract-for-radiation-counter-measure-drug--8503.html